Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.59 BRL | -1.72% | -0.66% | -1.78% |
Mar. 12 | Cosmetics group Natura's shares rise with higher margin, dividends even as loss widens | RE |
Mar. 12 | Transcript : Natura &Co Holding S.A., Q4 2023 Earnings Call, Mar 12, 2024 |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.87 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With a 2024 P/E ratio at 29.17 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.78% | 4.42B | B+ | ||
-3.10% | 251B | B- | ||
0.00% | 17.73B | - | - | |
+0.38% | 11.04B | A- | ||
-9.10% | 10.11B | A- | ||
+16.90% | 7.51B | B+ | ||
+10.15% | 5.97B | B | ||
-19.70% | 3.7B | C- | ||
-5.65% | 3.51B | B- | ||
-16.15% | 3.32B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NTCO3 Stock
- Ratings Natura &Co Holding S.A.